al LIP decision May 31 .S1 1 May 30 -Jun 3 BcI-2 intibex Anb-PDL1 (MPOL3280A1 Anti-79b Al2Cattzurnab vedotnl .SV Jun 3 Avastin May 30 Jun 3 Cobimetinib (MEK initiattc) "— Jun 21 -Jun 24 Oral °droner's MM. MM. Data in new tumor type (bladder cancer) at ASCO (analyst meeting on June 1) ROMULUS p